WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SLNO

Based on 4 analysts offering 12 month price targets for Soleno Therapeutics Inc.
Min Forecast
$40.00-16.04%
Avg Forecast
$60.75+27.52%
Max Forecast
$93.00+95.21%

Should I buy or sell SLNO stock?

Based on 4 analysts offering ratings for Soleno Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SLNO stock forecasts and price targets.

SLNO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-05
lockedlocked$00.00+00.00%2024-01-23
lockedlocked$00.00+00.00%2024-01-02
lockedlocked$00.00+00.00%2023-11-21

1 of 1

Forecast return on equity

Is SLNO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.31%

Forecast return on assets

Is SLNO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SLNO revenue forecast

What is SLNO's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$29.6M
Avg 2 year Forecast
$125.1M
Avg 3 year Forecast
$220.4M

SLNO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLNO$47.64$60.75+27.52%Strong Buy
KURA$20.77$31.75+52.86%Strong Buy
VCYT$20.63$25.33+22.80%Hold
ADMA$6.93$8.50+22.66%Strong Buy
NMRA$9.77$26.50+171.24%Strong Buy
View Top Biotech Stocks

Soleno Therapeutics Stock Forecast FAQ

Is Soleno Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: SLNO) stock is to Strong Buy SLNO stock.

Out of 4 analysts, 3 (75%) are recommending SLNO as a Strong Buy, 1 (25%) are recommending SLNO as a Buy, 0 (0%) are recommending SLNO as a Hold, 0 (0%) are recommending SLNO as a Sell, and 0 (0%) are recommending SLNO as a Strong Sell.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.

What is SLNO's revenue growth forecast for 2025-2027?

(NASDAQ: SLNO) Soleno Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.

Soleno Therapeutics's revenue in 2024 is $0.On average, 3 Wall Street analysts forecast SLNO's revenue for 2025 to be $987,405,006, with the lowest SLNO revenue forecast at $580,020,671, and the highest SLNO revenue forecast at $1,226,195,774. On average, 2 Wall Street analysts forecast SLNO's revenue for 2026 to be $4,179,089,031, with the lowest SLNO revenue forecast at $1,104,578,537, and the highest SLNO revenue forecast at $7,253,599,526.

In 2027, SLNO is forecast to generate $7,363,522,798 in revenue, with the lowest revenue forecast at $1,720,015,217 and the highest revenue forecast at $13,007,030,380.

What is SLNO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SLNO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SLNO's Price Target?

According to 4 Wall Street analysts that have issued a 1 year SLNO price target, the average SLNO price target is $60.75, with the highest SLNO stock price forecast at $93.00 and the lowest SLNO stock price forecast at $40.00.

On average, Wall Street analysts predict that Soleno Therapeutics's share price could reach $60.75 by Feb 5, 2025. The average Soleno Therapeutics stock price prediction forecasts a potential upside of 27.52% from the current SLNO share price of $47.64.

What is SLNO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SLNO) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.